Marion Biotech News

Marion Biotech had come under the scanner in December last year for its cough syrup Dok-1 that is suspected to have led to the death of 18 children who consumed it in Uzbekistan.

Three employees of pharmaceutical firm Marion Biotech, whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, were arrested by Noida Police.

The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan. In a medical product alert on Wednesday, the WHO said the "substandard medical products", manufactured by Marion Biotech, "are products that fail to meet quality standards or specifications and are therefore out of specification."

Marion Biotech, headquartered in Sector 67 of Noida, is a licensed manufacturer and holds license for manufacturing of Dok1 Max syrup  linked to deaths of 18 children in Uzbekistan.

The Health Ministry of Uzbekistan claimed that 18 children died after allegedly consuming cough syrup, 'Doc-1 Max', manufactured by Noida-based Marion Biotech.

Cough syrup-linked deaths in Uzbekistan: The Health Ministry of Uzbekistan earlier claimed that the 18 children had consumed cough syrup, 'Doc-1 Max', manufactured by Noida-based Marion Biotech.

The Health Ministry of Uzbekistan has issued a statement stating that the children who died had consumed cough syrup Dok-1 Max - manufactured by Noida-based Marion Biotech. The Dok 1 Max syrup and tablets are anti-cold medications. The development brings back the horror of the death of nearly 70 kids in Gambia allegedly due to the consumption of cough syrup made by an Indian pharmaceutical company.